Subscribe
shutterstock_1569359980_sundry-photography
shutterstock_1569359980_Sundry Photography
10 January 2023AmericasMuireann Bolger

Gilead avoids $1.2bn patent clash at SCOTUS

Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Trial set for Gilead HIV antitrust claims case
23 February 2023   Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.
Big Pharma
Gilead defeats immunity bid in hepatitis C patent case
7 March 2023   The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.
Big Pharma
Gilead defeats US govt in billion-dollar HIV drug patent suit
11 May 2023   Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
Trial set for Gilead HIV antitrust claims case
23 February 2023   Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.
Big Pharma
Gilead defeats immunity bid in hepatitis C patent case
7 March 2023   The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.
Big Pharma
Gilead defeats US govt in billion-dollar HIV drug patent suit
11 May 2023   Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

More on this story

Big Pharma
Trial set for Gilead HIV antitrust claims case
23 February 2023   Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.
Big Pharma
Gilead defeats immunity bid in hepatitis C patent case
7 March 2023   The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute.
Big Pharma
Gilead defeats US govt in billion-dollar HIV drug patent suit
11 May 2023   Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York